Last month, the e-commerce company released its second quarter earnings report, which featured a healthy consensus beat on revenue along with adjusted earnings per share of $0.02, a penny better than Q2/17. (All figures in US dollars unless noted otherwise.)
That topline made for a 62 per cent year over year increase, which was impressive but a notch lower than the 68 per cent growth recorded over the previous quarter. The slowdown in growth, combined with tepid guidance and news that the company would be offering $5 billion more in mixed securities over the next 25 months, were together enough to spook investors and drive down the stock, which is now 22 per cent off its most recent high.
But for those of us who like buying on the dip, think again, says Lato, who worries that SHOP could break through its 200-day moving average (currently at $133.05) and get into real trouble.
_____________________________________________
______________________________________________
“It’s a great company, obviously the darling of the Canadian tech world these days, but I just can’t buy stocks for my clients at 200x next year’s earnings,” says Lato, president of Padlock Investment, to BNN Bloomberg. “The stock is sort of bouncing off its 200-day moving average as of late, and so, I would be very concerned that if it broke that 200-day and I was holding it, I might be tempted to at least trim it a little bit.”
“As long as it holds, you’re fine, but I certainly wouldn’t be buying it here, especially since it’s so close to that 200-day,” he says. “I’d wait for an earnings miss where —and it’s happened many times before— the company has missed or a short report has come out and you get a bit of a break in the stock and a little better buying entry, maybe 150x instead of 200x.”
TD Cowen analyst Vince Valentini says the recent pullback in BCE (BCE Stock Quote, Chart, News, Analysts, Financials TSX:BCE) shares… [Read More]
Roth Capital Partners analyst Craig Irwin says VersaBank’s (VBNK Stock Quote, Chart, News, Analysts, Financials NASDAQ:VBNK) early commercial rollout of… [Read More]
Roth Capital Partners analyst Suji Desilva says Rocket Lab USA’s (Rocket Lab USA Stock Quote, Chart, News, Analysts, Financials NASDAQ:RKLB)… [Read More]
Research Capital analyst Andre Uddin says Medicenna Therapeutics (Medicenna Therapeutics Stock Quote, Chart, News, Analysts, Financials TSX:MDNA) has upcoming clinical… [Read More]
Beacon Securities analyst Russell Stanley says Firan Technology Group’s (Firan Technology Group Stock Quote, Chart, News, Analysts, Financials TSX:FTG) new… [Read More]
LionGuard Capital Management CEO and CIO Andrey Omelchak says Magellan Aerospace (Magellan Aerospcace Stock Quote, Chart, News, Analysts, Financials TSX:MAL)… [Read More]